148 related articles for article (PubMed ID: 36036273)
1. Clinical value of adjuvant therapy on the prognosis of ductal carcinoma of the major salivary gland: a large-scale cohort study.
Zhang D; Li L; Wen T; Ma F
Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):409-417. PubMed ID: 36036273
[TBL] [Abstract][Full Text] [Related]
2. Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database.
Jayaprakash V; Merzianu M; Warren GW; Arshad H; Hicks WL; Rigual NR; Sullivan MA; Seshadri M; Marshall JR; Cohan DM; Zhao Y; Singh AK
Head Neck; 2014 May; 36(5):694-701. PubMed ID: 23606370
[TBL] [Abstract][Full Text] [Related]
3. Cervical Lymph Node Metastatic Status and Adjuvant Therapy Predict the Prognosis of Salivary Duct Carcinoma.
Qian K; Di L; Guo K; Zheng X; Ji Q; Wang Z
J Oral Maxillofac Surg; 2018 Jul; 76(7):1578-1586. PubMed ID: 29544756
[TBL] [Abstract][Full Text] [Related]
4. The number and ratio of positive lymph nodes are independent prognostic factors for patients with major salivary gland cancer: Results from the surveillance, epidemiology, and End Results dataset.
Qian K; Sun W; Guo K; Zheng X; Sun T; Chen L; Xiang J; Li D; Wu Y; Ji Q; Wang Z
Eur J Surg Oncol; 2019 Jun; 45(6):1025-1032. PubMed ID: 30472214
[TBL] [Abstract][Full Text] [Related]
5. Number of positive lymph nodes affects oncologic outcomes in cN0 mucoepidermoid carcinoma of the major salivary gland.
Chang L; Wang Y; Wang Z; Xiao D; Song Q
Sci Rep; 2024 Apr; 14(1):9086. PubMed ID: 38643222
[TBL] [Abstract][Full Text] [Related]
6. Anatomic extent of lymph node metastases as an independent prognosticator in node-positive major salivary gland carcinoma: A study of the US SEER database and a Chinese multicenter cohort.
Shi X; Liu XK; An CM; Wei WJ; Tao Y; Ji Y; Zhang Y; Han W; Xue JC; Huang NS; Ma B; Zhang CP; Yang X; Wang KJ; Liu QJ; Liu Y; Wang Y; Lei BW; Yu PC; Hu JQ; Lu ZW; Hu WP; Tian YX; Wang YL; Ji QH
Eur J Surg Oncol; 2019 Nov; 45(11):2143-2150. PubMed ID: 31253544
[TBL] [Abstract][Full Text] [Related]
7. Nomogram-Based Prediction of Overall and Disease-Specific Survival in Patients With Postoperative Major Salivary Gland Squamous Cell Carcinoma.
Li L; Zhang D; Ma F
Technol Cancer Res Treat; 2022; 21():15330338221117405. PubMed ID: 35950233
[No Abstract] [Full Text] [Related]
8. Prognostic models for estimating survival of salivary duct carcinoma: a population-based study.
Zhang D; Li L
Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1939-1954. PubMed ID: 36422671
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of lymph node density in high-grade salivary gland cancers.
Hong HR; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2015 May; 111(6):784-9. PubMed ID: 25640975
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological characteristics and prognosis of uterine serous carcinoma: A SEER program analysis of 1016 cases.
Han Y; Liu C
J Obstet Gynaecol Res; 2021 Jul; 47(7):2460-2472. PubMed ID: 33870589
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy could benefit early-stage ER/PR positive mucinous breast cancer: A SEER-based analysis.
Gao HF; Li WP; Zhu T; Yang CQ; Yang M; Zhang LL; Ji F; Cheng MY; Li JQ; Wang K
Breast; 2020 Dec; 54():79-87. PubMed ID: 32947149
[TBL] [Abstract][Full Text] [Related]
12. Subgroups of parotid gland infiltrating ductal carcinoma benefit from postoperative radiotherapy: a population-based study.
Lv T; Wang Y; Wang X
Future Oncol; 2019 Mar; 15(8):885-895. PubMed ID: 30667284
[TBL] [Abstract][Full Text] [Related]
13. Head & neck acinar cell carcinoma: a population-based study using the seer registry.
Yibulayin F; Feng L; Wang M; Lu MM; Luo Y; Liu H; Yang ZC; Wushou A
BMC Cancer; 2020 Jul; 20(1):631. PubMed ID: 32641007
[TBL] [Abstract][Full Text] [Related]
14. A population-based competing risk survival analysis of patients with salivary duct carcinoma.
Ran J; Zou H; Li X; Guo F; Xu W; Han W
Ann Transl Med; 2020 Nov; 8(21):1355. PubMed ID: 33313100
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of PSMA, c-MET and E-cadherin in salivary duct carcinoma.
van Boxtel W; Uijen MJM; Verhaegh GW; Willems SM; Jonker MA; ; Schalken JA; van Engen-van Grunsven ICH; van Herpen CML
Oral Oncol; 2020 Nov; 110():105018. PubMed ID: 33039794
[TBL] [Abstract][Full Text] [Related]
16. Survival and prognostic factors of salivary gland malignant mixed tumor-not otherwise specified: A population-based analysis.
Soffer JM; Nassif SJ; Von Plato M; Chisholm J; O'Leary MA
Am J Otolaryngol; 2021; 42(6):103135. PubMed ID: 34171696
[TBL] [Abstract][Full Text] [Related]
17. Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis.
Haderlein M; Scherl C; Semrau S; Lettmaier S; Hecht M; Erber R; Iro H; Fietkau R; Agaimy A
Strahlenther Onkol; 2017 Nov; 193(11):961-970. PubMed ID: 28828496
[TBL] [Abstract][Full Text] [Related]
18. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis.
Wang D; Liu C; Zhou Y; Yan T; Li C; Yang Q; Xu Y; Zhao L; Pei Q; Tan F; Güngör C; Li Y
Radiat Oncol; 2020 May; 15(1):107. PubMed ID: 32404114
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients.
Otsuka K; Imanishi Y; Tada Y; Kawakita D; Kano S; Tsukahara K; Shimizu A; Ozawa H; Okami K; Sakai A; Sato Y; Ueki Y; Sato Y; Hanazawa T; Chazono H; Ogawa K; Nagao T
Ann Surg Oncol; 2016 Jun; 23(6):2038-45. PubMed ID: 26790669
[TBL] [Abstract][Full Text] [Related]
20. Salivary Duct Carcinoma: An Aggressive Salivary Gland Carcinoma with Morphologic Variants, Newly Identified Molecular Characteristics, and Emerging Treatment Modalities.
Rahman M; Griffith CC
Surg Pathol Clin; 2021 Mar; 14(1):111-126. PubMed ID: 33526216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
